Ingevity Corp.

  • Market Cap: Small Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: US45688C1071
USD
52.25
-0.29 (-0.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

199.97 k

Shareholding (Mar 2025)

FII

10.80%

Held by 121 FIIs

DII

25.51%

Held by 70 DIIs

Promoter

0.00%

How big is Ingevity Corp.?

22-Jun-2025

As of Jun 18, Ingevity Corp. has a market capitalization of 1,664.35 million, categorizing it as a Small Cap company, with net sales of 1,350.20 million and a net profit loss of 353.80 million reported for the latest four quarters. The balance sheet shows shareholder's funds of 195.20 million and total assets of 2,022.60 million.

As of Jun 18, Ingevity Corp. has a market capitalization of 1,664.35 million, categorizing it as a Small Cap company.<BR><BR>As of Jun 24, the company reported net sales of 1,350.20 million for the latest four quarters. However, it also experienced a net profit loss of 353.80 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 195.20 million and total assets amounting to 2,022.60 million.

Read More

What does Ingevity Corp. do?

22-Jun-2025

Ingevity Corporation manufactures specialty chemicals and high-performance carbon materials, with recent net sales of $284 million and a market cap of $1.66 billion. Key financial metrics include a P/E ratio of 7.00 and a return on equity of 97.71%.

Overview:<BR>Ingevity Corporation is a manufacturer of specialty chemicals and high-performance carbon materials, operating in the Chemicals & Petrochemicals industry with a small-cap market classification.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 284 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 20 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 1,664.35 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 7.00 <BR>Debt Equity: 5.62 <BR>Return on Equity: 97.71% <BR>Price to Book: 7.09<BR><BR>Contact Details:<BR>Address: 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC: 29405 <BR>Tel: ['1 843 7402300', '1 843 7402126'] <BR>Fax: 1 302 6365454 <BR>Website: https://www.ingevity.com/

Read More

Who are in the management team of Ingevity Corp.?

22-Jun-2025

As of March 2022, the management team of Ingevity Corp. includes Chairman Richard Kelson, CEO John Fortson, Lead Independent Director Frederick Lynch, and several Independent Directors: Jean Blackwell, Luis Fernandez-Moreno, J. Michael Fitzpatrick, and Diane Gulyas. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Ingevity Corp. includes the following individuals:<BR><BR>- Mr. Richard Kelson, Chairman of the Board<BR>- Mr. John Fortson, President, Chief Executive Officer, Chief Financial Officer, Treasurer, and Director<BR>- Mr. Frederick Lynch, Lead Independent Director<BR>- Ms. Jean Blackwell, Independent Director<BR>- Mr. Luis Fernandez-Moreno, Independent Director<BR>- Dr. J. Michael Fitzpatrick, Independent Director<BR>- Ms. Diane Gulyas, Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and overseeing its operations.

Read More

Is Ingevity Corp. overvalued or undervalued?

20-Sep-2025

As of February 21, 2024, Ingevity Corp. is considered risky and overvalued with a P/E ratio of 7 compared to the peer average of 11.75, and despite a strong year-to-date return, its long-term performance has significantly lagged behind the S&P 500.

As of 21 February 2024, the valuation grade for Ingevity Corp. has moved from expensive to risky, indicating a shift in market perception. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 7, which is significantly lower than the peer average of 11.75 for similar companies. Additionally, the EV to EBITDA ratio stands at 7.91, while the industry average is higher, suggesting that the company may not be generating sufficient earnings relative to its enterprise value.<BR><BR>In comparison with peers, Eastman Chemical Co. has a more attractive P/E ratio of 15.68, while Element Solutions, Inc. shows a P/E of 24.64, further highlighting Ingevity's relative valuation challenges. Despite a strong return of 41.94% year-to-date compared to the S&P 500's 12.22%, the long-term performance reflects a decline of 9.68% over three years, contrasting sharply with the S&P's 70.41% increase, reinforcing the notion that Ingevity may be overvalued in the current market landscape.

Read More

Is Ingevity Corp. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Ingevity Corp. has a bullish trend supported by daily moving averages and Bollinger Bands, despite a mildly bearish MACD signal on the weekly timeframe, and it has significantly outperformed the S&P 500 with a 77.49% return over the past year compared to 16.90%.

As of 24 October 2025, the technical trend for Ingevity Corp. has changed from mildly bullish to bullish. The current stance is bullish, driven by daily moving averages indicating bullish momentum, and both weekly and monthly Bollinger Bands also signaling bullish conditions. However, the MACD shows a mildly bearish signal on the weekly timeframe, which slightly tempers the overall bullish outlook. <BR><BR>In terms of performance, Ingevity has outperformed the S&P 500 significantly over the past year, returning 77.49% compared to the S&P 500's 16.90%, and has also shown strong returns year-to-date at 40.29% versus 15.47% for the benchmark.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Debt company with Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate 1.07% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Flat results in Jun 25

3

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

USD 2,441 Million (Small Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

10.26

stock-summary
Return on Equity

172.03%

stock-summary
Price to Book

20.22

Revenue and Profits:
Net Sales:
365 Million
(Quarterly Results - Jun 2025)
Net Profit:
-146 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.26%
0%
-11.26%
6 Months
26.06%
0%
26.06%
1 Year
9.93%
0%
9.93%
2 Years
30.04%
0%
30.04%
3 Years
-32.64%
0%
-32.64%
4 Years
-28.2%
0%
-28.2%
5 Years
-25.52%
0%
-25.52%

Ingevity Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.63%
EBIT Growth (5y)
1.07%
EBIT to Interest (avg)
4.50
Debt to EBITDA (avg)
3.10
Net Debt to Equity (avg)
5.62
Sales to Capital Employed (avg)
0.83
Tax Ratio
19.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
16.04%
ROE (avg)
42.05%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
7.20
EV to EBIT
10.87
EV to EBITDA
7.91
EV to Capital Employed
1.94
EV to Sales
2.23
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
17.82%
ROE (Latest)
97.71%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 86 Schemes (63.58%)

Foreign Institutions

Held by 121 Foreign Institutions (10.8%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 28.63% vs -4.92% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -814.63% vs 23.49% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "365.30",
          "val2": "284.00",
          "chgp": "28.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "111.80",
          "val2": "87.30",
          "chgp": "28.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.70",
          "val2": "20.60",
          "chgp": "-4.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-203.20",
          "val2": "-7.50",
          "chgp": "-2,609.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-146.50",
          "val2": "20.50",
          "chgp": "-814.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "236.00%",
          "val2": "219.70%",
          "chgp": "1.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -16.92% vs 1.59% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -7,868.52% vs -102.55% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,406.30",
          "val2": "1,692.80",
          "chgp": "-16.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "370.60",
          "val2": "395.30",
          "chgp": "-6.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "97.80",
          "val2": "93.30",
          "chgp": "4.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-640.40",
          "val2": "-173.80",
          "chgp": "-268.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-430.30",
          "val2": "-5.40",
          "chgp": "-7,868.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "186.50%",
          "val2": "150.00%",
          "chgp": "3.65%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
365.30
284.00
28.63%
Operating Profit (PBDIT) excl Other Income
111.80
87.30
28.06%
Interest
19.70
20.60
-4.37%
Exceptional Items
-203.20
-7.50
-2,609.33%
Consolidate Net Profit
-146.50
20.50
-814.63%
Operating Profit Margin (Excl OI)
236.00%
219.70%
1.63%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 28.63% vs -4.92% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -814.63% vs 23.49% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,406.30
1,692.80
-16.92%
Operating Profit (PBDIT) excl Other Income
370.60
395.30
-6.25%
Interest
97.80
93.30
4.82%
Exceptional Items
-640.40
-173.80
-268.47%
Consolidate Net Profit
-430.30
-5.40
-7,868.52%
Operating Profit Margin (Excl OI)
186.50%
150.00%
3.65%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -16.92% vs 1.59% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -7,868.52% vs -102.55% in Dec 2023

stock-summaryCompany CV
About Ingevity Corp. stock-summary
stock-summary
Ingevity Corp.
Chemicals & Petrochemicals
Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.
Company Coordinates stock-summary
Company Details
4920 O'HEAR AVENUE, SUITE 400 , NORTH CHARLESTON SC : 29405
stock-summary
Tel: 1 843 74023001 843 7402126
stock-summary
Registrar Details